IS8227A - Lyf - Google Patents

Lyf

Info

Publication number
IS8227A
IS8227A IS8227A IS8227A IS8227A IS 8227 A IS8227 A IS 8227A IS 8227 A IS8227 A IS 8227A IS 8227 A IS8227 A IS 8227A IS 8227 A IS8227 A IS 8227A
Authority
IS
Iceland
Prior art keywords
drugs
Prior art date
Application number
IS8227A
Other languages
English (en)
Inventor
Lindstedt-Alstermark Eva-Lotte
Maria Persdotter Boije Anna
Holm Patrik
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27636748&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS8227(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS8227A publication Critical patent/IS8227A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
IS8227A 2003-06-18 2005-01-11 Lyf IS8227A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0314075.3A GB0314075D0 (en) 2003-06-18 2003-06-18 Therapeutic agents
PCT/GB2004/002554 WO2004113282A1 (en) 2003-06-18 2004-06-16 Therapeutic agents

Publications (1)

Publication Number Publication Date
IS8227A true IS8227A (is) 2006-01-10

Family

ID=27636748

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8227A IS8227A (is) 2003-06-18 2005-01-11 Lyf

Country Status (21)

Country Link
US (1) US20060199857A1 (is)
EP (1) EP1638927A1 (is)
JP (1) JP2006527747A (is)
KR (1) KR20060023994A (is)
CN (1) CN1835917A (is)
AR (1) AR044828A1 (is)
AU (1) AU2004249474B2 (is)
BR (1) BRPI0411536A (is)
CA (1) CA2529297A1 (is)
CO (1) CO5630027A2 (is)
GB (1) GB0314075D0 (is)
IL (1) IL172632A0 (is)
IS (1) IS8227A (is)
MX (1) MXPA05013719A (is)
NO (1) NO20056005L (is)
RU (1) RU2005141062A (is)
SA (1) SA04250193B1 (is)
TW (1) TW200503999A (is)
UY (1) UY28370A1 (is)
WO (1) WO2004113282A1 (is)
ZA (1) ZA200510260B (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0104333D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
CA2489834C (en) 2002-06-20 2006-10-03 Astrazeneca Ab Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
GB0314131D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0427524D0 (en) 2004-12-16 2005-01-19 Astrazeneca Ab Chemical process
US8927760B2 (en) * 2010-02-18 2015-01-06 The Asan Foundation Colchicine derivatives or pharmaceutically acceptable salts thereof, method for preparing said derivatives, and pharmaceutical composition comprising said derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU170228B (is) * 1974-04-19 1977-04-28
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
MA26634A1 (fr) * 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
CN1543451A (zh) * 2001-06-07 2004-11-03 过氧化物酶体增生剂激活的受体的调节剂
UA82835C2 (en) * 2001-12-03 2008-05-26 Reddys Lab Ltd Dr ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon
SE0104333D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
GB0314130D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314131D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314260D0 (en) * 2003-06-19 2003-07-23 Astrazeneca Ab Therapeutic agents

Also Published As

Publication number Publication date
ZA200510260B (en) 2007-01-31
AR044828A1 (es) 2005-10-05
MXPA05013719A (es) 2006-06-27
CO5630027A2 (es) 2006-04-28
RU2005141062A (ru) 2006-07-10
IL172632A0 (en) 2006-04-10
GB0314075D0 (en) 2003-07-23
WO2004113282A1 (en) 2004-12-29
CA2529297A1 (en) 2004-12-29
TW200503999A (en) 2005-02-01
SA04250193B1 (ar) 2007-08-13
KR20060023994A (ko) 2006-03-15
NO20056005L (no) 2006-02-24
EP1638927A1 (en) 2006-03-29
UY28370A1 (es) 2005-01-31
AU2004249474B2 (en) 2008-05-15
CN1835917A (zh) 2006-09-20
US20060199857A1 (en) 2006-09-07
BRPI0411536A (pt) 2006-08-01
AU2004249474A1 (en) 2004-12-29
JP2006527747A (ja) 2006-12-07

Similar Documents

Publication Publication Date Title
IS7946A (is) Lyf
DE602004017700D1 (de) Transmukosen verabreichung
EP1620118A4 (en) REVERSIBLE PEGYLATED MEDICAMENTS
ATE363383T1 (de) Schlingenware
DE602004027504D1 (de) Aminobenzophenonverbindungen
DK1587478T3 (da) Farmaceutisk sammensætning
NO20035315D0 (no) Farmasöytiske kombinasjoner
AT502792A5 (de) Düsenanpressvorrichtung
DE602004004736D1 (de) Haarwaschmittel
DK1597171T3 (da) Terapeutisk mikroskum
ATA662003A (de) Trink-mundstück
DE50304722D1 (de) Fungizide Wirkstoffkombinationen
EP1694640A4 (en) ANTI CANCER AGENTS
ATE446959T1 (de) Chromenonindole
GB2401043B (en) Drug
NO20034952D0 (no) Farmasöytiske forbindelser
NL1025908A1 (nl) Farmaceutische combinatie.
ATE406350T1 (de) Prolinylarylacetamide
DE112004001429D2 (de) Pharmazeutischer Wirkstoff
ITRM20030053A1 (it) Associazione di farmaci antidiabetici.
AT500001B8 (de) Münzscheideeinrichtung
ATA1802003A (de) Verbundhonring
FI20030224A0 (fi) Uudet farmaseuttiset käytöt
EP1624073A4 (en) DRUG
DE10316511B4 (de) Teigportionierer